Abstract
Peak sales are an important metric in the pharmaceutical industry. Specifically, managers are focused on the height-of-peak-sales and the time required achieving peak sales. We analyze how order of entry and quality affect the level of peak sales and the time-to-peak-sales of pharmaceutical brands. We develop a growth model that includes these two variables as well as control variables for own and competitive marketing activities. We find that early entrants achieve peak sales later, and they have higher peak-sales levels. High-quality brands achieve peak sales earlier, and their peak-sales levels are higher. In addition, quality has a moderating effect on the order of entry effect on time-to-peak-sales. Our results indicate that late entrants have longer expected time-to-peak-sales when they introduce a brand with high quality.
Original language | English |
---|---|
Pages (from-to) | 429-460 |
Number of pages | 32 |
Journal | Quantitative Marketing and Economics |
Volume | 8 |
Issue number | 4 |
Early online date | 13 Aug 2010 |
DOIs | |
Publication status | Published - Dec 2010 |
Bibliographical note
Creative common license- attributionKeywords
- peak-sales metrics
- brand growth
- econometric models
- market entry
- pharmaceutical marketing